PPIDT00288

Drug Information
NameProthrombin
SequenceMAHVRGLQLPGCLALAALCSLVHSQHVFLAPQQARSLLQRVRRANTFLEEVRKGNLERECVEETCSYEEAFEALESSTATDVFWAKYTACETARTPRDKLAACLEGNCAEGLGTNYRGHVNITRSGIECQLWRSRYPHKPEINSTTHPGADLQENFCRNPDSSTTGPWCYTTDPTVRRQECSIPVCGQDQVTVAMTPRSEGSSVNLSPPLEQCVPDRGQQYQGRLAVTTHGLPCLAWASAQAKALSKHQDFNSAVQLVENFCRNPDGDEEGVWCYVAGKPGDFGYCDLNYCEEAVEEETGDGLDEDSDRAIEGRTATSEYQTFFNPRTFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE
DrugBank_IDDB11311
Typebiotech
IndicationProthrombin is administered as part of a cocktail containing several coagulation factors. Along with other blood coagulation factors, it is used to reverse acquired coagulation factor deficiency induced by Vitamin K antagonist (VKA, e.g., warfarin) therapy in adult patients with a need for an urgent surgery/invasive procedure.[L50517]

Dosage Forms
Form Route Strength
Injection Intravenous
Powder, for solution Intravenous
Injection, powder, lyophilized, for solution; kit Intravenous
Powder, for solution Parenteral
Kit; powder, for solution Intravenous
Injection, powder, for solution Intravenous drip
520 IU/vial
Injection, powder, for solution Parenteral
Injection, powder, for solution Intravenous
Solution Intravenous
Target Information
Role Uniprot_ID Gene_Name Entity_Name Organism Actions Internal link
target P02671 FGA Fibrinogen alpha chain Homo sapiens cleavage Link
target P02675 FGB Fibrinogen beta chain Homo sapiens cleavage Link
target P00488 F13A1 Coagulation factor XIII A chain Homo sapiens agonist Link
target Q96IY4 CPB2 Carboxypeptidase B2 Homo sapiens agonist Link
enzyme P00742 F10 Coagulation factor X Homo sapiens substrate Link